 The Advocate Development Program, or the ADP, is a 12-month training program for new patient advocates. Our goal is to educate them about the entire drug development process and where they can affect changes as advocates. We start by explaining the diseases of myeloma and alamylidosis, how clinical trials operate, how evidence-based advocacy works, how drugs are approved and reimbursed in Europe, and how decisions are made at the EU level to help care policy. As a non-clinical person, I was intimidated perhaps in the beginning with all of these scientific papers and the evolving area of multiple myeloma research and treatment regimes. But through this program, I feel I've developed a much better understanding and appreciation of the clinical aspects and a more realistic expectation of the journey that it takes from discovering a new drug, the phases that a clinical trial has to go through, these next steps about authorization that takes a long time, and then importantly, there's a big, long journey to take from authorization to reimbursement for patients to actually benefit. I understand that much better now than I would have before I did this course. I wouldn't definitely hesitate once again to go again with the process. Basically, it answers all my expectations of being learning, learning important, learning about the disease, and meeting the field of patients quite important, meeting professionals being in the industry or the physicians, for instance. So this is quite important. And on a personal note, it helped me to better accept the disease and to find a way to go along with my life and helping the other ones who are in the same situation. Apart from the benefits of the learning from the program itself, it's the friends that you make, the networks, the opportunities that I would never have had to go to the European Hematology Association Conference, to go to the European Cancer Conference, and apart from the formal learning from that, it's all of that informal networking and getting ideas from other people and other countries that you can hopefully apply in your own situation. The Advocates Development Program is open to MP members, patients, advocates, and carers from across Europe. We keep the cohort size small between six and eight participants to ensure optimal learning environments, and we recruit at the end of each year and kick off the program in January.